Delivery Order SPE2DR25D3202-SPE2DR26F8E5N
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,557.17 to AmerisourceBergen Drug Corp for COMBIPATCH 0.05-0.14 mg transdermal patches (8-count packaging). This is a competitively awarded, firm fixed-price delivery order with no set-aside designation, with an ultimate completion date of December 16, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order on December 9, 2025, for COMBIPATCH 0.05-0.14 mg transdermal patches (8 count) valued at $1,463.45. This non-competitive, firm fixed price delivery order is set to be completed by December 10, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government,...
- The Defense Logistics Agency awarded a delivery order valued at $1,253.93 to AmerisourceBergen Drug Corp for Combipatch 0.05-0.25 mg transdermal patches (8-unit supply) on January 9, 2026, with an ultimate completion date of January 12, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a...
- The Defense Logistics Agency awarded a $2,151.98 firm fixed-price delivery order to AmerisourceBergen Drug Corp for COMBIPATCH 0.05-0.25 MG transdermal patches (8-count packaging) on November 3, 2025, with an ultimate completion date of November 4, 2025. The contract involves no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen Drug Corp's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,426.20 to AmerisourceBergen Drug Corp for COMBIPATCH TDBW 8S, a transdermal pharmaceutical product. The contract, issued on January 2, 2026, with an ultimate completion date of January 5, 2026, utilizes firm fixed pricing with no set-aside designation, indicating open competition. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 14, 2026, for a supply of Combipatch 0.05-0.14 mg transdermal patches (8-count package) with a ceiling value of $1,018.94. The contract employs firm fixed-price pricing and is not set aside for any specific business category, indicating it was competitively awarded. Performance will be executed from the company's Conshohocken, Pennsylvania location, with an ultimate completion date of January 15,...
- The Defense Logistics Agency (DLA) awarded a $3,430.71 delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Combipatch 0.05-0.14 mg transdermal patches (8-count units). This firm fixed-price delivery order is non-competitive and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.999 billion through December 2026. Performance is scheduled for completion by September 3,...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $1,136.83 to AmerisourceBergen Drug Corp for COMBIPATCH 0.05-0.25 mg patches (8-count) with an ultimate completion date of August 18, 2025. This non-set-aside contract was competitively awarded and represents a specific product delivery under the company's larger pharmaceutical supply relationship with the federal government. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a...
- The Defense Logistics Agency awarded a delivery order valued at $1,791.52 to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Combipatch 0.05-0.14 mg patches (8-count units). This is a firm fixed price, non-set-aside contract with a completion date of July 31, 2025, and performance occurring at the vendor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical supplier for federal...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 11, 2025, for COMBIPATCH 0.05-0.14 MG transdermal patches (8-count packaging) with a ceiling value of $1,679.70. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The ultimate completion date is set for July 14, 2025, and performance will occur at the vendor's facility in Conshohocken, Pennsylvania. This delivery order represents a...
- SPE2DR25D3202Indefinite Delivery Contract
- SPE2DR25D3202-SPE2DR26F8E5NDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,647.30 to AmerisourceBergen Drug Corp for COMBIPATCH 0.05-0.14 MG transdermal patches (8-count package) on January 15, 2026, with completion scheduled for January 16, 2026. This is a firm fixed-price, non-set-aside contract with performance to be executed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at up to $999,999,999.00 through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities. The competitive award reflects the contractor's demonstrated capability to meet federal procurement requirements and serve customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 1/14/26 |